METABOLIC / SINGLE
AOD9604
2MG · 5MG · 10MGThis content is intended for educational and research reference only and does not constitute medical advice, diagnosis, or treatment. Experimental compounds are for research use only and are not for human consumption. Always consult qualified healthcare providers before starting any therapy.
Research Overview
A modified fragment of human growth hormone (hGH 176-191) studied in fat-metabolism research.
Available Strengths
- 2MG (2AD)
- 5MG (5AD)
- 10MG (10AD)
Research Protocol
Reference two-phase schedule
| Period | Dose | U-100 units | Volume |
|---|---|---|---|
| Weeks 1–4 (initial) | 0.3 mg | 45 | 0.45 mL |
| Weeks 5–12+ (maintenance) | 0.5 mg | 75 | 0.75 mL |
Reconstitution
≈0.667 mg/mL once reconstituted (≈667 mcg/mL)
- Draw 3.0 mL of bacteriostatic water per 2 mg vial.
- Inject slowly along the vial wall; swirl gently until dissolved.
Research context
Studied for supporting lipolysis and inhibiting lipogenesis without the insulin-resistance or IGF-1 elevation associated with full-length growth hormone.
Storage
−20°C, stable 1+ year. 2–8°C, use within 3–4 weeks; avoid freeze–thaw cycles.
Research Notes
- For educational and research reference only. Not medical advice and not intended for unsupervised human use.
References
Source reference: PeptideDosages.com · 2026-08-18 · Exact strength match with the cited source